Expression of NK cell and monocyte receptors in critically ill patients - potential biomarkers of sepsis

Scandinavian Journal of Immunology

Volumn 81, Issue 4, 2015, Pages 249-258

  Kjaergaard A G ^a,b   Nielsen, J S ^a,c   Tonnesen E ^a   Krog, J ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NCR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NATURAL KILLER CELL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; AGED; BLOOD; CLINICAL TRIAL; FLOW CYTOMETRY; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MULTICENTER STUDY; NONPARAMETRIC TEST;

AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SEPSIS; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925034853     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12272     Document Type: Article

References (23)

1. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
2. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-8.
3. Vincent JL, Opal SM, Marshall JC et al. Sepsis definitions: time for change. Lancet 2013;381:774-5.
4. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8.
5. Chiche L, Forel JM, Thomas G et al. The role of natural killer cells in sepsis. J Biomed Biotechnol 2011;2011:986491.
6. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40.
7. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9.
8. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-90.
9. Marras F, Bozzano F, De Maria A. Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol 2011;2011:152430.
10. Moretta A, Bottino C, Mingari MC et al. What is a natural killer cell? Nat Immunol 2002;3:6-8.
11. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168:554-61.
12. Chow JC, Young DW, Golenbock DT et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-92.
13. Knaus WA, Draper EA, Wagner DP et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
14. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
15. Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 1968;97:9-29.
16. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
17. Munoz C, Carlet J, Fitting C et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-54.
18. Fumeaux T, Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 2002;166:1475-82.
19. Forel JM, Chiche L, Thomas G et al. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS ONE 2012;7:e50446.
20. Andaluz-Ojeda D, Iglesias V, Bobillo F et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011;15:R243.
21. Calvano JE, Agnese DM, Um JY et al. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 2003;20:415-9.
22. Brandl K, Gluck T, Huber C et al. TLR-4 surface display on human monocytes is increased in septic patients. Eur J Med Res 2005;10:319-24.
23. Brunialti MK, Martins PS, Barbosa de Carvalho H et al. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 2006;25:351-7.